Veracyte products
Biopharma Services
TMExplore - Tumor Tissue-Based Technology
Veracyte offers a unique multiplex tissue imaging and analysis approach combining multiple technologies perfectly adapted to the comprehensive characterization of the tumor microenvironment.
Brightplext - Multiplex Cell Technology
HalioDx has developed advanced, reliable and customizable technologies to help immunotherapies developers in rationalizing and accelerating the pace of clinical programs from early phases to registration.
Diagnostic
Immunoscore - Immune-Oncology IVD Family Assays
Use our immune-oncology IVD solutions IMMUNOSCORE in Localized Colon Cancer and IMMUNOSCORE IC in Non-Small Cell Lung Cancer to improve patient care management with immune contexture information.
Immunoscore
Immunoscore - For Colon Cancer
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III localized colon cancer to inform them about the optimal treatment duration for their patients.
Immunoscore - For Rectal Cancer
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation studies.